{"id":"https://openalex.org/W7214403232","doi":"https://doi.org/10.1158/1538-7445.pancreatic26-a137","title":"Abstract A137: Chemotherapy utilization and outcomes in patients with metastatic pancreatic adenocarcinoma","display_name":"Abstract A137: Chemotherapy utilization and outcomes in patients with metastatic pancreatic adenocarcinoma","publication_year":2026,"publication_date":"2026-09-25","ids":{"openalex":"https://openalex.org/W7214403232","doi":"https://doi.org/10.1158/1538-7445.pancreatic26-a137"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.pancreatic26-a137","doi":"https://doi.org/10.1158/1538-7445.pancreatic26-a137","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.pancreatic26-a137","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5152933774","display_name":"Shubham Pant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shubham Pant","raw_affiliation_strings":["1MD Anderson Cancer Center, Houston, TX,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MD Anderson Cancer Center, Houston, TX,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040126333","display_name":"Pranoti Pradhan","orcid":"https://orcid.org/0000-0002-6423-0484","observed_orcids":["https://orcid.org/0000-0002-6423-0484","https://orcid.org/0009-0008-4890-0645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pranoti Pradhan","raw_affiliation_strings":["2ConcertAI, LLC, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2ConcertAI, LLC, Cambridge, MA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152873849","display_name":"Yuexi Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuexi Wang","raw_affiliation_strings":["2ConcertAI, LLC, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2ConcertAI, LLC, Cambridge, MA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053396154","display_name":"Aliza R. Karpes Matusevich","orcid":"https://orcid.org/0000-0002-5717-6918","observed_orcids":["https://orcid.org/0000-0002-5717-6918"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aliza R. Karpes Matusevich","raw_affiliation_strings":["2ConcertAI, LLC, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2ConcertAI, LLC, Cambridge, MA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152775405","display_name":"Ziyu Lan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ziyu Lan","raw_affiliation_strings":["2ConcertAI, LLC, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2ConcertAI, LLC, Cambridge, MA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009814440","display_name":"Brandon Kent","orcid":"https://orcid.org/0000-0002-6175-0898","observed_orcids":["https://orcid.org/0000-0002-6175-0898"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Kent","raw_affiliation_strings":["3Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152776957","display_name":"Clay Gustafson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clay Gustafson","raw_affiliation_strings":["3Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137204369","display_name":"John Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Graham","raw_affiliation_strings":["3Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103819689","display_name":"Preeti S. Bajaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Preeti S. Bajaj","raw_affiliation_strings":["3Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"18_Supplement_2","first_page":"A137","last_page":"A137"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-pancreatic-adenocarcinoma","display_name":"metastatic pancreatic adenocarcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemotherapy-use","display_name":"chemotherapy use","score":0.8130000233650208},{"id":"https://openalex.org/keywords/chemotherapy-intolerance","display_name":"chemotherapy intolerance","score":0.9150000214576721},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9120000004768372},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.6909999847412109},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.7179999947547913},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.46399998664855957},{"id":"https://openalex.org/keywords/de-novo-metastatic-disease","display_name":"de novo metastatic disease","score":0.7210000157356262},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.965499997138977},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6248000264167786},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6068999767303467},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.5430999994277954},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4034999907016754},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3652999997138977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3513000011444092},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.34540000557899475},{"id":"https://openalex.org/C2987381348","wikidata":"https://www.wikidata.org/wiki/Q517656","display_name":"Electronic records","level":2,"score":0.3368000090122223},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.33559998869895935},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.32510000467300415},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.302700012922287},{"id":"https://openalex.org/C2910665457","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Metastatic adenocarcinoma","level":4,"score":0.289900004863739},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.28760001063346863},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2856999933719635},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2822999954223633},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.27619999647140503},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2745000123977661},{"id":"https://openalex.org/C2992026798","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic ductal adenocarcinoma","level":4,"score":0.2745000123977661},{"id":"https://openalex.org/C3019952477","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Health records","level":3,"score":0.25529998540878296}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.pancreatic26-a137","doi":"https://doi.org/10.1158/1538-7445.pancreatic26-a137","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.pancreatic26-a137","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7162688067","https://openalex.org/W7162658573","https://openalex.org/W3092476531","https://openalex.org/W4406869456","https://openalex.org/W4407065180","https://openalex.org/W2907822839","https://openalex.org/W4399118537","https://openalex.org/W2790735606","https://openalex.org/W2602692503","https://openalex.org/W4301606058"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Metastatic":[2],"pancreatic":[3,364],"adenocarcinoma":[4,365],"(mPDAC)":[5],"is":[6,39],"associated":[7],"with":[8,22,75,97,108,265,362],"poor":[9,43],"prognosis":[10],"and":[11,55,71,114,134,144,170,202,213,222,240,247,286,293,305,317,358,380],"limited":[12,56],"treatment":[13,192,329],"options.":[14],"While":[15,308],"guidelines":[16],"recommend":[17],"chemotherapy":[18],"(CTx)":[19],"for":[20,137,327,331],"patients":[21,28,74,101,179,208,218,249,264,273,361],"good":[23],"performance":[24],"status":[25],"(PS),":[26],"many":[27],"do":[29,80],"not":[30,81],"receive":[31,82,316],"CTx":[32,60,136,147,309],"or":[33,46,83,162,276],"discontinue":[34],"shortly":[35],"after":[36],"initiation.":[37],"Non-treatment":[38],"often":[40],"attributed":[41],"to":[42,68,86,123,142,210,278,283],"PS,":[44],"comorbidities,":[45],"organ":[47],"dysfunction;":[48],"however,":[49],"treatment-related":[50],"factors":[51],"including":[52],"toxicity":[53],"burden":[54],"effectiveness":[57],"of":[58,73,118,151,160,189,263,272,369],"available":[59],"options":[61,330],"may":[62],"also":[63,322],"contribute.":[64],"This":[65,89],"study":[66,90],"aimed":[67],"understand":[69],"characteristics":[70],"outcomes":[72,312,359],"de":[76,109,266],"novo":[77,110,267],"mPDAC":[78,111],"who":[79,303,315],"are":[84],"intolerant":[85],"CTx.":[87,307],"Methods:":[88],"used":[91],"ConcertAI":[92],"Patient360\u2122":[93],"electronic":[94],"health":[95],"records":[96],"linked":[98],"claims.":[99],"Adult":[100],"were":[102,106,126,173,185,198,219,274],"included":[103],"if":[104],"they":[105],"diagnosed":[107],"between":[112],"1/2020\u20133/2025":[113],"had":[115,214,223,250],">3":[116],"months":[117,233,237,242],"follow-up":[119],"unless":[120,140],"censored":[121],"due":[122,141],"death.":[124],"Patients":[125],"categorized":[127],"into":[128],"3":[129],"cohorts:":[130],"CTx-untreated,":[131,235],"CTx-tolerant":[132,201,227],"(initiated":[133,146],"continued":[135],">90":[138],"days":[139,150,157],"progression),":[143],"CTx-intolerant":[145,217,244,248],"within":[148,155,193],"90":[149,156,194],"diagnosis":[152],"but":[153],"discontinued":[154],"without":[158],"evidence":[159],"progression":[161],"re-treatment).":[163],"Demographics,":[164],"clinical":[165],"characteristics,":[166],"overall":[167],"survival":[168],"(OS),":[169],"resource":[171,252,294],"utilization":[172,253,295,357],"evaluated.":[174],"Results:":[175],"Of":[176],"the":[177,370],"2708":[178],"meeting":[180],"eligibility":[181],"criteria,":[182],"953":[183],"(35%)":[184],"CTx-untreated.":[186],"A":[187],"total":[188],"1635":[190],"initiated":[191],"days;":[195],"1105":[196],"(41%)":[197],"classified":[199],"as":[200,205],"530":[203],"(20%)":[204],"CTx-intolerant.":[206],"CTx-untreated":[207,246],"tended":[209],"be":[211],"older":[212,221,284],"worse":[215,224,287],"PS.":[216,288],"slightly":[220],"PS":[225],"than":[226,270,300],"patients.":[228,245],"Median":[229],"OS":[230],"was":[231,290],"1.74":[232],"in":[234,238,243,297,360,378],"11.37":[236],"CTx-tolerant,":[239],"2.63":[241],"higher":[251,296],"per":[254,256],"patient":[255],"month.":[257],"Conclusions:":[258],"In":[259],"a":[260,324],"large":[261],"cohort":[262],"mPDAC,":[268],"more":[269],"half":[271],"untreated":[275],"unable":[277],"tolerate":[279,318],"CTx,":[280],"possibly":[281],"related":[282],"age":[285],"Survival":[289],"substantially":[291],"shorter":[292],"these":[298,320],"groups":[299],"among":[301,313],"those":[302,314],"received":[304],"tolerated":[306],"demonstrates":[310],"improved":[311,328],"it,":[319],"findings":[321],"highlight":[323],"significant":[325],"need":[326],"mPDAC.":[332],"Citation":[333],"Format:":[334],"Shubham":[335],"Pant,":[336],"Pranoti":[337],"Pradhan,":[338],"Yuexi":[339],"Wang,":[340],"Aliza":[341],"R.":[342],"Karpes":[343],"Matusevich,":[344],"Ziyu":[345],"Lan,":[346],"Brandon":[347],"Kent,":[348],"Clay":[349],"Gustafson,":[350],"John":[351],"Graham,":[352],"Preeti":[353],"S.":[354],"Bajaj.":[355],"Chemotherapy":[356],"metastatic":[363],"[abstract].":[366],"In:":[367],"Proceedings":[368],"AACR":[371],"Conference":[372],"on":[373],"Pancreatic":[374],"Cancer:":[375],"New":[376],"Frontiers":[377],"Biology":[379],"Therapeutic":[381],"Development;":[382],"2026":[383],"Sep":[384],"25-28;":[385],"San":[386],"Diego,":[387],"CA.":[388],"Philadelphia":[389],"(PA):":[390],"AACR;":[391],"Cancer":[392],"Res":[393],"2026;86(18_Suppl_2):Abstract":[394],"nr":[395],"A137.":[396]},"counts_by_year":[],"updated_date":"2026-10-03T13:16:28.481748","created_date":"2026-09-26T00:00:00"}